Clinical Trial Update: Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating batoclimab for active thyroid eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• Batoclimab (batoclimab)

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Thyroid Eye Disease | Phase 3 | Status: COMPLETED